Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism
Open Access
- 1 June 2011
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 121 (6), 2242-2253
- https://doi.org/10.1172/jci44031
Abstract
Probiotic bacteria can potentially have beneficial effects on the clinical course of several intestinal disorders, but our understanding of probiotic action is limited. We have identified a probiotic bacteria–derived soluble protein, p40, from Lactobacillus rhamnosus GG (LGG), which prevents cytokine-induced apoptosis in intestinal epithelial cells. In the current study, we analyzed the mechanisms by which p40 regulates cellular responses in intestinal epithelial cells and p40’s effects on experimental colitis using mouse models. We show that the recombinant p40 protein activated EGFR, leading to Akt activation. Activation of EGFR by p40 was required for inhibition of cytokine-induced apoptosis in intestinal epithelial cells in vitro and ex vivo. Furthermore, we developed a pectin/zein hydrogel bead system to specifically deliver p40 to the mouse colon, which activated EGFR in colon epithelial cells. Administration of p40-containing beads reduced intestinal epithelial apoptosis and disruption of barrier function in the colon epithelium in an EGFR-dependent manner, thereby preventing and treating DSS-induced intestinal injury and acute colitis. Furthermore, p40 activation of EGFR was required for ameliorating colon epithelial cell apoptosis and chronic inflammation in oxazolone-induced colitis. These data define what we believe to be a previously unrecognized mechanism of probiotic-derived soluble proteins in protecting the intestine from injury and inflammation.Keywords
This publication has 57 references indexed in Scilit:
- MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligandsProceedings of the National Academy of Sciences of the United States of America, 2010
- Probiotics: progress toward novel therapies for intestinal diseasesCurrent Opinion in Gastroenterology, 2010
- Inflammation in the Intestinal Tract: Pathogenesis and TreatmentDigestive Diseases, 2009
- The gut microbiota shapes intestinal immune responses during health and diseaseNature Reviews Immunology, 2009
- Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosisProceedings of the National Academy of Sciences of the United States of America, 2008
- Mucosal macrophages and the regulation of immune responses in the intestineImmunology Letters, 2008
- Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanismAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- The fundamental basis of inflammatory bowel diseaseJCI Insight, 2007
- Soluble Proteins Produced by Probiotic Bacteria Regulate Intestinal Epithelial Cell Survival and GrowthGastroenterology, 2007
- Comparative genomics of the lactic acid bacteriaProceedings of the National Academy of Sciences of the United States of America, 2006